Moreover, YY1 cooperates with transcription factor 3 (E2F3) proteins to enhance the expression of microtubule-related genes, promote the ovarian cancer cell mesenchymal transition, and increase the resistance to paclitaxel and docetaxel [149]. Here, YY1 is linked to ovarian carcinoma.